TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company